0001214659-24-014784.txt : 20240917 0001214659-24-014784.hdr.sgml : 20240917 20240815125245 ACCESSION NUMBER: 0001214659-24-014784 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biodexa Pharmaceuticals Plc CENTRAL INDEX KEY: 0001643918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1 CASPIAN POINT STREET 2: CASPIAN WAY CITY: CARDIFF STATE: X0 ZIP: CF10 4DQ BUSINESS PHONE: 44 (0)1235 888300 MAIL ADDRESS: STREET 1: 1 CASPIAN POINT STREET 2: CASPIAN WAY CITY: CARDIFF STATE: X0 ZIP: CF10 4DQ FORMER COMPANY: FORMER CONFORMED NAME: Midatech Pharma Plc DATE OF NAME CHANGE: 20150602 CORRESP 1 filename1.htm

Biodexa Pharmaceuticals PLC

1 Caspian Point

Caspian Way

Cardiff, CF10 4DQ

United Kingdom

August 15, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Tyler Howes

Re:

Biodexa Pharmaceuticals PLC
Registration Statement on Form F-1 (File No. 333-281489)
Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Biodexa Pharmaceuticals PLC (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form F-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on August 19, 2024, or as soon as practicable thereafter.

The Registrant requests that it be notified of such effectiveness by a telephone call to Jason S. McCaffrey of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4416 or by an email to JSMcCaffrey@mintz.com.

Thank you for your assistance. If you should have any questions, please contact Mr. McCaffrey at (617) 348-4416.

	Very truly yours,


	BIODEXA PHARMACEUTICALS PLC


	By: /s/ Stephen Stamp
	Name: Stephen Stamp
	Title: Chief Executive Officer & Chief Financial Officer

cc:

Jason S. McCaffrey, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.